Alexandria Equities LLC

Alexandria Equities LLC

Alexandria Equities LLC

Overview
Type of Company

Private

In The News
Business Wire
September 8, 2014
Flex Pharma Raises $40 Million
Executives & Employees

Managing Member

Paths to Alexandria Equities LLC
Potential Connections via
Relationship Science
You
Alexandria Equities LLC
Investments
Details Hidden

Intra-Cellular Therapies, Inc. operates as a biopharmaceutical company which focuses on the discovery and clinical development of innovative, small molecule drugs that address underserved medical needs in neuropsychiatric and neurological disorders by targeting intracellular signaling mechanisms within the central nervous system. The company's technology addresses diseases of the central nervous system, including schizophrenia, cognition, Parkinson's disease, anxiety, depression, Alzheimer's disease, sleep, and those related to women's health. Its products include clinical development plan for schizophrenia and unique mechanism of action. Intra-Cellular Therapies was founded by Paul Greengard, Sharon Mates and Allen A. Fienberg on May 22, 2001 and is headquartered in New York, NY.

Details Hidden

Salmedix, Inc. develops oncology and small molecule drugs to treat hematological malignancies. The company's product, Treanda, is currently in Phase II clinical trials in the United States and Canada for the treatment of indolent (slowly progressing) non-Hodgkin's lymphoma. It was founded in 2000 and is located in San Diego, CA.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Alexandria Equities LLC. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Alexandria Equities LLC's profile does not indicate a business or promotional relationship of any kind between RelSci and Alexandria Equities LLC.